Zobrazeno 1 - 10
of 1 072
pro vyhledávání: '"SIMPSON JA"'
Publikováno v:
Journal of Epidemiology and Community Health (1979-), 2016 Sep 01. 70, A35-A36.
Externí odkaz:
https://www.jstor.org/stable/26383572
Autor:
O'Flaherty, K, Chan, J-A, Cutts, JC, Zaloumis, SG, Ashley, EA, Phyo, AP, Drew, DR, Dondorp, AM, Day, NP, Dhorda, M, Fairhurst, RM, Lim, P, Amaratunga, C, Pukrittayakamee, S, Hien, TT, Htut, Y, Mayxay, M, Faiz, MA, Mokuolu, OA, Onyamboko, MA, Fanello, C, Takashima, E, Tsuboi, T, Theisen, M, Nosten, F, Beeson, JG, Simpson, JA, White, NJ, Fowkes, FJI
Publikováno v:
O'Flaherty, K, Chan, J-A, Cutts, J C, Zaloumis, S G, Ashley, E A, Phyo, A P, Drew, D R, Dondorp, A M, Day, N P, Dhorda, M, Fairhurst, R M, Lim, P, Amaratunga, C, Pukrittayakamee, S, Hien, T T, Htut, Y, Mayxay, M, Faiz, M A, Mokuolu, O A, Onyamboko, M A, Fanello, C, Takashima, E, Tsuboi, T, Theisen, M, Nosten, F, Beeson, J G, Simpson, J A, White, N J & Fowkes, F J I 2022, ' Anti-gametocyte antigen humoral immunity and gametocytemia during treatment of uncomplicated falciparum malaria : A multi-national study ', Frontiers in Cellular and Infection Microbiology, vol. 12, pp. 804470 . https://doi.org/10.3389/fcimb.2022.804470
Frontiers in cellular and infection microbiology, 12:804470. Frontiers Media S.A.
Frontiers in cellular and infection microbiology, 12:804470. Frontiers Media S.A.
IntroductionUnderstanding the human immune response to Plasmodium falciparum gametocytes and its association with gametocytemia is essential for understanding the transmission of malaria as well as progressing transmission blocking vaccine candidates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b599e81209d4db17a225e50112464389
https://ora.ox.ac.uk/objects/uuid:e2116d13-ce4a-47a0-a04e-0e534fd40ede
https://ora.ox.ac.uk/objects/uuid:e2116d13-ce4a-47a0-a04e-0e534fd40ede
Autor:
Rae, JD, Nosten, S, Kajeechiwa, L, Wiladphaingern, J, Parker, DM, Landier, J, Thu, AM, Dah, H, Be, A, Cho, WC, Paw, KN, Paw, ES, Shee, PB, Poe, C, Nu, C, Nyaw, B, Simpson, JA, Devine, A, Maude, RJ, Moo, KL, Min, MC, Thwin, MM, Tun, SW, Nosten, FH
Publikováno v:
Malaria journal, vol 21, iss 1
Malaria Journal
Malaria Journal, 2022, 21 (1), pp.175. ⟨10.1186/s12936-022-04175-w⟩
Malaria Journal
Malaria Journal, 2022, 21 (1), pp.175. ⟨10.1186/s12936-022-04175-w⟩
Background The collection and utilization of surveillance data is essential in monitoring progress towards achieving malaria elimination, in the timely response to increases in malaria case numbers and in the assessment of programme functioning. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21177af916984356e8dc8eda60a5dc1d
https://escholarship.org/uc/item/57n2j5c1
https://escholarship.org/uc/item/57n2j5c1
Autor:
McGready, R, Lee, SJ, Wiladphaingern, J, Ashley, EA, Rijken, MJ, Boel, M, Simpson, JA, Paw, MK, Pimanpanarak, M, Mu, Oh, Singhasivanon, P, White, NJ, Nosten, FH
Publikováno v:
In The Lancet Infectious Diseases May 2012 12(5):388-396
Autor:
Dharmaratne, ADVTT, Dini, S, O'Flaherty, K, Price, DJ, Beeson, J, McGready, R, Nosten, F, Fowkes, FJI, Simpson, JA, Zaloumis, SG
Publikováno v:
Malaria Journal. 21
Background Malaria remains a major public health threat and tools sensitive to detect infections in low malaria transmission areas are needed to progress elimination efforts. Pregnant women are particularly vulnerable to malaria infections. Throughou
Autor:
Watson, JA, Commons, RJ, Tarning, J, Simpson, JA, Llanos Cuentas, A, Lacerda, MVG, Green, JA, Koh, GCKW, Chu, CS, Nosten, FH, Price, RN, Day, NPJ, White, NJ
Tafenoquine is a newly licensed antimalarial drug for the radical cure of Plasmodium vivax malaria. The mechanism of action and optimal dosing are uncertain. We pooled individual data from 1102 patients and 72 healthy volunteers studied in the pre-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107a38001530d49ed2404bc8a1984537
https://hdl.handle.net/20.500.12866/13004
https://hdl.handle.net/20.500.12866/13004
Autor:
Ley, B, Alam, MS, Satyagraha, AW, Phru, CS, Thriemer, K, Tadesse, D, Shibiru, T, Hailu, A, Kibria, MG, Hossain, MS, Rahmat, H, Poespoprodjo, JR, Khan, WA, Simpson, JA, Price, RN
Publikováno v:
PLoS neglected tropical diseases. 16(5)
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the re
Autor:
Taylor, WRJ, Thriemer, K, von Seidlein, L, Yuentrakul, P, Assawariyathipat, T, Assefa, A, Auburn, S, Chand, K, Chau, NH, Cheah, PY, Dong, LT, Dhorda, M, Degaga, TS, Devine, A, Ekawati, LL, Fahmi, F, Hailu, A, Hasanzai, MA, Hien, TT, Khu, H, Ley, B, Lubell, Y, Marfurt, J, Mohammad, H, Moore, KA, Naddim, MN, Pasaribu, AP, Pasaribu, S, Promnarate, C, Rahim, AG, Sirithiranont, P, Solomon, H, Sudoyo, H, Sutanto, I, Thanh, NV, Tuyet-Trinh, NT, Waithira, N, Woyessa, A, Yamin, FY, Dondorp, A, Simpson, JA, Baird, JK, White, NJ, Day, NP, Price, RN
Publikováno v:
Lancet (London, England)
Summary Background Primaquine is the only widely used drug that prevents Plasmodium vivax malaria relapses, but adherence to the standard 14-day regimen is poor. We aimed to assess the efficacy of a shorter course (7 days) of primaquine for radical c
Autor:
Setyadi, A, Arguni, E, Kenangalem, E, Hasanuddin, A, Lampah, DA, Thriemer, K, Anstey, NM, Sugiarto, P, Simpson, JA, Price, RN, Douglas, NM, Poespoprodjo, JR
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-11 (2019)
Background: Primaquine (PQ) prevents relapses of vivax malaria but may induce severe haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient patients. Data on the safety of primaquine in infants are limited. Methods: A retrospective, hospita
Autor:
Commons, RJ, Simpson, JA, Thriemer, K, Hossain, MS, Douglas, NM, Humphreys, GS, Sibley, CH, Guerin, PJ, Price, RN
Publikováno v:
The Lancet. Infectious Diseases
Summary Background A 14-day course of primaquine is used for radical cure of Plasmodium vivax and Plasmodium ovale malaria only. We quantified the risk of P vivax parasitaemia after treatment of Plasmodium falciparum with commonly used antimalarial d